Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 38

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Mislocalization of protein kinase A drives pathology in Cushing’s syndrome

Omar, Mitchell H., Byrne, Dominic P., Jones, Kiana N., Lakey, Tyler M., Collins, Kerrie B., Lee, Kyung-Soon, Daly, Leonard A., Forbush, Katherine A., Lau, Ho-Tak, Golkowski, Martin, McKnight, G. Stanley, Breault, David T., Lefrançois-Martinez, Anne-Marie, Martinez, Antoine, Eyers, Claire E., Baird, Geoffrey S., Ong, Shao-En, Smith, F. Donelson, Eyers, Patrick A., Scott, John D. · 2022 · Cell Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2022.111073

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 57

  1. Amunjela, 2019, The role of the Popeye domain containing gene family in organ homeostasis, Cell, 8
  2. Baffi, 2021, mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif, Sci. Signal., 14, eabe4509, 10.1126/scisignal.abe4509 · DOI
  3. Bathon, 2019, Alterations in protein kinase A substrate specificity as a potential cause of cushing syndrome, Endocrinology, 160, 447, 10.1210/en.2018-00775 · DOI · Paper page
  4. Bauman, 2006, Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes, Molecular cell, 23, 925, 10.1016/j.molcel.2006.07.025 · DOI · Paper page
  5. Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome, N. Engl. J. Med., 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
  6. Bock, 2021, Optical mapping of cAMP signaling at the nanometer scale, Cell, 184, 2793, 10.1016/j.cell.2021.04.043 · doi:10.1016/j.cell.2021.04.043
  7. Branon, 2018, Efficient proximity labeling in living cells and organisms with TurboID, Nat. Biotechnol., 36, 880, 10.1038/nbt.4201 · DOI · Paper page
  8. Byrne, 2016, cAMP-dependent protein kinase (PKA) complexes probed by complementary differential scanning fluorimetry and ion mobility-mass spectrometry, Biochem. J., 473, 3159, 10.1042/BCJ20160648 · DOI
  9. Daly, 2021, Oxygen-dependent changes in binding partners and post-translational modifications regulate the abundance and activity of HIF-1α/2α, Science signaling, 14, eabf6685, 10.1126/scisignal.abf6685 · DOI
  10. Davies, 2002, Mutations of the BRAF gene in human cancer, Nature, 417, 949, 10.1038/nature00766 · DOI · Paper page
  11. Di Dalmazi, 2020, RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights, J. Clin. Endocrinol. Metab., 105, e4459, 10.1210/clinem/dgaa616 · DOI
  12. Dostmann, 1990, Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3’, 5’-cyclic phosphorothioates, J. Biol. Chem., 265, 10484, 10.1016/S0021-9258(18)86973-3 · DOI · Paper page
  13. Dumontet, 2018, PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal, JCI Insight, 3, e98394, 10.1172/jci.insight.98394 · DOI
  14. Espiard, 2018, Activating PRKACB somatic mutation in cortisol-producing adenomas, JCI Insight, 3, 98296, 10.1172/jci.insight.98296 · DOI
  15. Ferries, 2017, Evaluation of parameters for confident phosphorylation site localization using an Orbitrap fusion Tribrid mass spectrometer, J. Proteome Res., 16, 3448, 10.1021/acs.jproteome.7b00337 · DOI
  16. Freedman, 2013, Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells, Dev. Cell., 26, 666, 10.1016/j.devcel.2013.07.016 · DOI · Paper page
  17. Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat. Genet., 46, 613, 10.1038/ng.2956 · DOI · Paper page
  18. Hernández-Ramírez, 2018, Genetics of Cushing's syndrome, Endocrinol. Metab. Clin. N. Am., 47, 275, 10.1016/j.ecl.2018.02.007 · DOI
  19. Holderfield, 2014, Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond, Nat. Rev. Cancer., 14, 455, 10.1038/nrc3760 · DOI · Paper page
  20. Horn, 2014, KinomeXplorer: an integrated platform for kinome biology studies, Nat. Methods, 11, 603, 10.1038/nmeth.2968 · DOI · Paper page
  21. Isensee, 2018, PKA-RII subunit phosphorylation precedes activation by cAMP and regulates activity termination, J. Cell. Biol., 217, 2167, 10.1083/jcb.201708053 · DOI
  22. Kwan, 2016, DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2, Genesis, 30, 2696
  23. Lacroix, 2015, Cushing's syndrome, Lancet, 386, 913, 10.1016/S0140-6736(14)61375-1 · DOI · Paper page
  24. Langeberg, 2015, Signalling scaffolds and local organization of cellular behaviour, Nat. Rev. Mol. Cell. Biol., 16, 232, 10.1038/nrm3966 · DOI · Paper page
  25. Liu, 2017, Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector, Sci. Rep., 7, 2193, 10.1038/s41598-017-02460-2 · DOI · Paper page
  26. Lubner, 2017, Cushing's syndrome mutant PKA L 205R exhibits altered substrate specificity, FEBS. Lett., 591, 459, 10.1002/1873-3468.12562 · DOI · Paper page
  27. Ma, 2019, Identification of a PRKAR1A mutation (c.491_492delTG) in familial cardiac myxoma: a case report, Medicine, 98, e14866, 10.1097/MD.0000000000014866 · DOI
  28. Musheshe, 2018, cAMP: from long-range second messenger to nanodomain signalling, Trends. Pharmacol. Sci., 39, 209, 10.1016/j.tips.2017.11.006 · DOI · Paper page
  29. Newton, 2003, Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm, Biochem. J., 370, 361, 10.1042/bj20021626 · DOI · Paper page
  30. Niswender, 2005, Cre recombinase-dependent expression of a constitutively active mutant allele of the catalytic subunit of protein kinase A, Genesis, 43, 109, 10.1002/gene.20159 · DOI
  31. Omar, 2020, AKAP signaling islands: venues for precision pharmacology, Trends. Pharmacol. Sci., 41, 933, 10.1016/j.tips.2020.09.007 · DOI
  32. Palencia-Campos, 2020, Germline and mosaic variants in PRKACA and PRKACB cause a multiple congenital malformation syndrome, Am. J. Hum. Genet., 107, 977, 10.1016/j.ajhg.2020.09.005 · DOI · Paper page
  33. Pereira, 2019, MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors, J. Cell. Biochem., 120, 894, 10.1002/jcb.27451 · DOI
  34. Poppe, 2008, Cyclic nucleotide analogs as probes of signaling pathways, Nat. Methods, 5, 277, 10.1038/nmeth0408-277 · DOI · Paper page
  35. Ragazzon, 2006, Adrenocorticotropin-dependent changes in SF-1/DAX-1 ratio influence steroidogenic genes expression in a novel model of glucocorticoid-producing adrenocortical cell lines derived from targeted tumorigenesis, Endocrinology, 147, 1805, 10.1210/en.2005-1279 · DOI · Paper page
  36. Rinaldi, 2019, Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system, Nat. Commun., 10, 2572, 10.1038/s41467-019-10037-y · DOI
  37. Rosenberg, 2002, Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues, Ann. N. Y. Acad. Sci., 968, 65, 10.1111/j.1749-6632.2002.tb04327.x · DOI · Paper page
  38. Sandberg, 1991, Characterization of Sp-5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3’, 5’-monophosphorothioate (Sp-5, 6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells, Biochem. J., 279, 521, 10.1042/bj2790521 · DOI
  39. Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
  40. Scott, 2009, Cell signaling in space and time: where proteins come together and when they're apart, Science, 326, 1220, 10.1126/science.1175668 · DOI · Paper page
  41. Shabb, 2001, Physiological substrates of cAMP-dependent protein kinase, Chem. Rev., 101, 2381, 10.1021/cr000236l · DOI · Paper page
  42. Smith, 2017, Local protein kinase A action proceeds through intact holoenzymes, Science, 356, 1288, 10.1126/science.aaj1669 · DOI · Paper page
  43. Smith, 2010, AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade, Nat. Cell. Biol., 12, 1242, 10.1038/ncb2130 · DOI
  44. Smith, 2018, Single nucleotide polymorphisms alter kinase anchoring and the subcellular targeting of A-kinase anchoring proteins, Proc. Natl. Acad. Sci. U S A, 115, E11465, 10.1073/pnas.1816614115 · DOI
  45. Smith, 2013, Intrinsic disorder within an AKAP-protein kinase A complex guides local substrate phosphorylation, Elife, 2, e01319, 10.7554/eLife.01319 · DOI
  46. Stratakis, 2018, Cyclic AMP-dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next, J. Pathol., 244, 257, 10.1002/path.5014 · DOI · Paper page
  47. Szklarczyk, 2019, STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets, Nucleic. Acids. Res., 47, 10.1093/nar/gky1131 · DOI · Paper page
  48. Taskén, 2004, Localized effects of cAMP mediated by distinct routes of protein kinase A, Physiol. Rev., 84, 137, 10.1152/physrev.00021.2003 · DOI · Paper page
  49. Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell. Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
  50. Turnham, 2016, Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology, Genewatch, 577, 101
  51. Turnham, 2019, An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma, Elife, 8, e44187, 10.7554/eLife.44187 · DOI
  52. Van, 2021, Protein kinase C fusion proteins are paradoxically loss of function in cancer, J. Biol. Chem., 296, 100445, 10.1016/j.jbc.2021.100445 · DOI
  53. Viña, 2021, cAMP compartmentalization in cerebrovascular endothelial cells: new therapeutic opportunities in alzheimer's disease, Cells, 10, 10.3390/cells10081951 · DOI
  54. Yarwood, 2020, Special issue on "new advances in cyclic AMP signalling"-an editorial overview, Cells, 9, 10.3390/cells9102274 · DOI
  55. Yu, 2013, The Hippo pathway: regulators and regulations, Genes & development, 27, 355, 10.1101/gad.210773.112 · DOI · Paper page
  56. Yu, 2019, ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling, Aging, 11, 12295, 10.18632/aging.102572 · DOI
  57. Zhang, 2012, Structure and allostery of the PKA RIIβ tetrameric holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page

Cited by

Metadata

Authors
Omar, M. H., Byrne, D. P., Jones, K. N., Lakey, T. M., Collins, K. B., Lee, K.-S., Daly, L. A., Forbush, K. A., Lau, H.-T., Golkowski, M., McKnight, G. S., Breault, D. T., Lefrançois-Martinez, A.-M., Martinez, A., Eyers, C. E., Baird, G. S., Ong, S.-E., Smith, F. D., Eyers, P. A., & Scott, J. D.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2022-07
Volume
40
Issue
2
Pages
111073
ISSN
2211-1247
Cited by
38
References
7
Language
en
Licence
Funders
  • National Institutes of Health (F32DK121415, R01DK119192, R01DK119186, R01GM129090)
  • Biotechnology and Biological Sciences Research Council (BB/S018514/1, BB/T018127/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.